Pfizer and Bristol-Myers Squibb Alliance

www.pfizer.com

www.bms.com

In 2007, Pfizer and Bristol Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. This global alliance combines Bristol-Myers Squibb’s long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise in this field.

Feedback
Click here to
send us feedback